FPF
CMTA

FNY Partners Fund’s Clementia Pharmaceuticals Inc. CMTA Stock Holding History

FNY Partners Fund’s Portfolio CMTA Stock Details CMTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$4K Buy
+300
New +$4.88K ﹤0.01% 307

Other funds holding CMTA

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

FNY Partners Fund's CMTA Position: Q1 2018 in Review

FNY Partners Fund opened a new position in Clementia Pharmaceuticals Inc. (CMTA) in Q1 2018: 300 shares worth $4K. The stake represents ﹤0.01% of the portfolio and ranks #307 among its holdings.

38 funds tracked by Wall St. Rank hold CMTA as of Q1 2018.

  • FNY Partners Fund held 300 shares of Clementia Pharmaceuticals Inc. worth $4K as of Q1 2018.
  • Clementia Pharmaceuticals Inc. was a new FNY Partners Fund position in Q1 2018.
  • Clementia Pharmaceuticals Inc. made up ﹤0.01% of FNY Partners Fund's portfolio in Q1 2018, its #307 holding.
  • 38 funds tracked by Wall St. Rank held Clementia Pharmaceuticals Inc. as of Q1 2018.

Based on FNY Partners Fund's 13F filing for Q1 2018, filed 18 Apr 2018.